CONTINUING EDUCATION SESSIONS

3:15PM -

4:15PM | BREAKOUT SESSION: Focus on SepsisTherapeutic Debates

Christopher Edwards, PharmD, BCPS, FASHP; Brian Kopp, PharmD, BCPS, FCCM

Educational Goal: This session will go beyond the guidelines into the cutting edge of sepsis research. Two practitioners will advocate for different approaches that are currently supported by the literature and the audience will decide which approach makes the most sense.

Learning Objectives (Pharmacists Only):

• Critique the evidence for and against a liberal fluid resuscitation in early management of sepsis.

• Evaluate the evidence for “maximum” doses of norepinephrine when treating patients with septic shock.

• Evaluate the literature for the use of balanced salt solutions or saline as resuscitative fluids in patients with sepsis and septic shock.

3:15PM

- 4:15PM | BREAKOUT SESSION: Focus on Hyperlipidemia: How Old Is Too Old? Debating the Use of Statins for Primary Prevention in the Elderly-Therapeutic Debate

Ariane Guthrie, PharmD, BCPS; Thu Nguyen, PharmD, BCGP, BCPS

Educational Goal: Beyond age 75 years, clinical practice guidelines are unclear about whether to continue statins for primary prevention. This clinical debate will explore the data (or lack thereof) for use of statins in primary prevention among patients aged 75 years and older.

Learning Objectives (Pharmacists Only):

• Evaluate the evidence for initiating statin therapy for primary prevention in older adults.

• Evaluate the evidence for deprescribing statins in persons with advanced age.

• Compare risks and benefits of statins for primary prevention in older adults.

4:30PM

- 5:30PM

| GENERAL SESSION: Demystifying Pain Management – Overview of the 2022 CDC Opioid Guidelines Update

Christopher Edwards, PharmD, BCPS, FASHP; Amy Kennedy, PharmD, BCACP

Educational Goal: This session will allow attendees to review and apply the updated CDC Opioid Guidelines to patient care scenarios in a variety of settings. Recommendations from the guidelines will be discussed during the session, along with supporting evidence. Where applicable, interactive patient cases will be presented to allow for application of the principle highlighted by the recommendation.

Pharmacist Learning Objectives:

• Given a patient case, develop a plan to taper the patient off of long-term opioid therapy.

• Evaluate a patient case to determine if co-prescribing of naloxone is appropriate.

• Differentiate between substances detectable and not detectable on commonly available opioid screening assays.

Technician Learning Objectives:

• Identify long-term opioids used in pain management.

• Discuss the purpose of co-prescribing naloxone.